These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28491038)

  • 41. Lesion of cholinergic neurons in nucleus basalis enhances response to general anesthetics.
    Leung LS; Petropoulos S; Shen B; Luo T; Herrick I; Rajakumar N; Ma J
    Exp Neurol; 2011 Apr; 228(2):259-69. PubMed ID: 21295026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electron-microscopic examination of effects of yokukansan, a traditional Japanese medicine, on degeneration of cerebral cells in thiamine-deficient rats.
    Iizuka S; Kawakami Z; Imamura S; Yamaguchi T; Sekiguchi K; Kanno H; Ueki T; Kase Y; Ikarashi Y
    Neuropathology; 2010 Oct; 30(5):524-36. PubMed ID: 20337951
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Yokukansan inhibits morphine tolerance and physical dependence in mice: the role of α₂A-adrenoceptor.
    Nakagawa T; Nagayasu K; Nishitani N; Shirakawa H; Sekiguchi K; Ikarashi Y; Kase Y; Kaneko S
    Neuroscience; 2012 Dec; 227():336-49. PubMed ID: 23069764
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ameliorative effect of yokukansan on vacuous chewing movement in haloperidol-induced rat tardive dyskinesia model and involvement of glutamatergic system.
    Sekiguchi K; Kanno H; Yamaguchi T; Ikarashi Y; Kase Y
    Brain Res Bull; 2012 Dec; 89(5-6):151-8. PubMed ID: 22982367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease.
    Okahara K; Ishida Y; Hayashi Y; Inoue T; Tsuruta K; Takeuchi K; Yoshimuta H; Kiue K; Ninomiya Y; Kawano J; Yoshida K; Noda S; Tomita S; Fujimoto M; Hosomi J; Mitsuyama Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):532-6. PubMed ID: 20170698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Yokukansan Inhibits the Development of Morphine Tolerance by Regulating Presynaptic Proteins in DRG Neurons.
    Ohashi Y; Sakhri FZ; Ikemoto H; Okumo T; Adachi N; Sunagawa M
    Front Pharmacol; 2022; 13():862539. PubMed ID: 35662731
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuropsychiatric symptoms of cholinergic deficiency occur with degradation of the projections from the nucleus basalis of Meynert.
    van Dalen JW; Caan MWA; van Gool WA; Richard E
    Brain Imaging Behav; 2017 Dec; 11(6):1707-1719. PubMed ID: 27787708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of Yokukansankachimpihange on Memantine-induced Dizziness in Mice with Memory Impairment].
    Shimoyama T; Aoki Y; Kaneda M; Han LK; Michihara S; Takahashi R
    Yakugaku Zasshi; 2021; 141(7):955-960. PubMed ID: 34193655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nerve growth factor and the monosialoganglioside GM1: analogous and different in vivo effects on biochemical, morphological, and behavioral parameters of adult cortically lesioned rats.
    Garofalo L; Cuello AC
    Exp Neurol; 1994 Feb; 125(2):195-217. PubMed ID: 8313938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of choline acetyltransferase activity between the nucleus basalis of Meynert and the cerebral cortex.
    Koshimura K; Kato T; Yohyama I; Nakamura S; Kameyama M
    Neurosci Res; 1987 Apr; 4(4):330-6. PubMed ID: 3601249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Yokukansan, a traditional Japanese medicine, decreases head-twitch behaviors and serotonin 2A receptors in the prefrontal cortex of isolation-stressed mice.
    Ueki T; Mizoguchi K; Yamaguchi T; Nishi A; Sekiguchi K; Ikarashi Y; Kase Y
    J Ethnopharmacol; 2015 May; 166():23-30. PubMed ID: 25732836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nucleus basalis of Meynert neuronal activity in Parkinson's disease.
    Lee DJ; Milosevic L; Gramer R; Sasikumar S; Al-Ozzi TM; De Vloo P; Dallapiazza RF; Elias GJB; Cohn M; Kalia SK; Hutchison WD; Fasano A; Lozano AM
    J Neurosurg; 2020 Feb; 132(2):574-582. PubMed ID: 30797189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Yokukansan promotes hippocampal neurogenesis associated with the suppression of activated microglia in Gunn rat.
    Furuya M; Miyaoka T; Tsumori T; Liaury K; Hashioka S; Wake R; Tsuchie K; Fukushima M; Ezoe S; Horiguchi J
    J Neuroinflammation; 2013 Dec; 10():145. PubMed ID: 24305622
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analgesic Efficacy of a Combination of Fentanyl and a Japanese Herbal Medicine "
    Akanuma Y; Kato M; Takayama Y; Ikemoto H; Adachi N; Ohashi Y; Yogi W; Okumo T; Tsukada M; Sunagawa M
    Medicines (Basel); 2020 Dec; 7(12):. PubMed ID: 33348580
    [No Abstract]   [Full Text] [Related]  

  • 55. The Kampo medicine Yokukansan (YKS) enhances nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells.
    Terada K; Matsushima Y; Matsunaga K; Takata J; Karube Y; Ishige A; Chiba K
    Bosn J Basic Med Sci; 2018 Aug; 18(3):224-233. PubMed ID: 28961087
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Hamaguchi T; Tsutsui-Kimura I; F Tanaka K; Mimura M
    Nagoya J Med Sci; 2017 Aug; 79(3):351-362. PubMed ID: 28878440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Malonate-induced degeneration of basal forebrain cholinergic neurons: attenuation by lamotrigine, MK-801, and 7-nitroindazole.
    Connop BP; Boegman RJ; Beninger RJ; Jhamandas K
    J Neurochem; 1997 Mar; 68(3):1191-9. PubMed ID: 9048766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Traditional Japanese Herbal Medicine Yokukansan Targets Distinct but Overlapping Mechanisms in Aged Mice and in the 5xFAD Mouse Model of Alzheimer's Disease.
    Kaushik R; Morkovin E; Schneeberg J; Confettura AD; Kreutz MR; Senkov O; Dityatev A
    Front Aging Neurosci; 2018; 10():411. PubMed ID: 30631278
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Japanese Herbal Medicine Yokukansan Exerted Antioxidant and Analgesic Effects in an Experimental Rat Model of Hunner-Type Interstitial Cystitis.
    Inoue T; Tsukada M; Tsunokawa Y; Maeda Y; Fukuoka S; Fukagai T; Ogawa Y; Sunagawa M
    Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744072
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of lesions of the nucleus basalis magnocellularis and of treatment with posatirelin on cholinergic neurotransmission enzymes in the rat cerebral cortex.
    Sabbatini M; Coppi G; Maggioni A; Olgiati V; Panocka I; Amenta F
    Mech Ageing Dev; 1998 Aug; 104(2):183-94. PubMed ID: 9792196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.